The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy
Abstract
"Collateral damage" is a term used to refer to ecological adverse effects of antibiotic therapy; namely, the selection of drug-resistant organisms and the unwanted development of colonization or infection with multidrug-resistant organisms. The risk of such damage can be assessed for different antibiotic classes by a variety of epidemiologic studies. Cephalosporin use has been linked to subsequent infection with vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, beta-lactam-resistant Acinetobacter species, and Clostridium difficile. Quinolone use has been linked to infection with methicillin-resistant Staphylococcus aureus and with increasing quinolone resistance in gram-negative bacilli, such as Pseudomonas aeruginosa. Neither third-generation cephalosporins nor quinolones appear suitable for sustained use in hospitals as "workhorse" antibiotic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Paterson, D. L., Ko, W.-C., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00008 · Cited by 631
Self-citationWiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Fink, M. P., Snydman, D. R., Niederman, M. S., Leeper, K. V., Johnson, R. H., Heard, S. O., Wunderink, R. G., Caldwell, J. W., Schentag, J. J., & Siami, G. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.547 · Cited by 461
Graffunder, E. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf009 · Cited by 411
Paterson, D. L., Mulazimoglu, L., Casellas, J. M., Ko, W.-C., Goossens, H., Von Gottberg, A., Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormack, J. G., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313719 · Cited by 386
Self-citationRice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.118 · Cited by 313
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1515 · Cited by 301
Fridkin, S. K., Edwards, J. R., Courval, J. M., Hill, H., Tenover, F. C., Lawton, R., Gaynes, R. P., McGowan, J. E., & for the Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-3-200108070-00009 · Cited by 279
Harris, A. D., Karchmer, T. B., Carmeli, Y., & Samore, M. H. (2001) · Clinical Infectious Diseases · doi:10.1086/319600 · Cited by 262
Gaynes, R., Rimland, D., Killum, E., Ken Lowery, H., Johnson II, T. M., Killgore, G., & Tenover, F. C. (2004) · Clinical Infectious Diseases · doi:10.1086/381551 · Cited by 251
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/322667 · Cited by 227
Asensio, A., Oliver, A., González-Diego, P., Baquero, F., Pérez-Díaz, J. C., Ros, P., Cobo, J., Palacios, M., Lasheras, D., & Cantón, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313590 · Cited by 187
Gerding, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/382084 · Cited by 175
Harris, A. D., Samore, M. H., Lipsitch, M., Kaye, K. S., Perencevich, E., & Carmeli, Y. (2002) · Clinical Infectious Diseases · doi:10.1086/340533 · Cited by 171
Zervos, M., Hershberger, E., Nicolau, D. P., Ritchie, D. J., Blackner, L. K., Coyle, E. A., Donnelly, A. J., Eckel, S. F., Eng, R. H. K., Hiltz, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/379709 · Cited by 169
Harbarth, S., Harris, A. D., Carmeli, Y., & Samore, M. H. (2001) · Clinical Infectious Diseases · doi:10.1086/322677 · Cited by 169
Landman, D., Chockalingam, M., & Quale, J. M. (1999) · Clinical Infectious Diseases · doi:10.1086/514743 · Cited by 161
PATTERSON, J. E., Hardin, T. C., Kelly, C. C., Carvajal-García, R., & Jorgensen, J. H. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501787 · Cited by 152
Campillo, B., Dupeyron, C., Richardet, J. P., Mangeney, N., & Leluan, G. (1998) · Clinical Infectious Diseases · doi:10.1086/520273 · Cited by 145
Bradley, S. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.261 · Cited by 143
Dupeyron, C., Mangeney, N., Sedrati, L., Campillo, B., Fouet, P., & Leluan, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.340 · Cited by 128
Dziekan, G., Hahn, A., Thüne, K., Schwarzer, G., Schäfer, K., Daschner, F. D., & Grundmann, H. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0846 · Cited by 120
Bisognano, C., Vaudaux, P. E., Rohner, P., Lew, D. P., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1428-1437.2000 · Cited by 119
Bisognano, C., Vaudaux, P. E., Lew, D. P., Ng, E. Y., & Hooper, D. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.906 · Cited by 113
Settle, Wilcox, Fawley, Corrado, & Hawkey (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00428.x · Cited by 109
Lautenbach, E., LaRosa, L. A., Marr, A. M., Nachamkin, I., Bilker, W. B., & Fishman, N. O. (2003) · Clinical Infectious Diseases · doi:10.1086/346153 · Cited by 109
Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea
Yip, C., Loeb, M. B., Salama, S. E., Moss, L., & Olde, J. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501954 · Cited by 105
Campillo, B., Dupeyron, C., & Richardet, J. P. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801006288 · Cited by 98
Quale, J. M., Landman, D., Bradford, P. A., Visalli, M. A., Ravishankar, J., Flores, C., Mayorga, D., Vangala, K., & Adedeji, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342577 · Cited by 96
Pallarés, R. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130103010 · Cited by 95
Nelson, D. E., Auerbach, S. B., Baltch, A. L., Desjardin, E. K., Beck‐Sagué, C. M., Rheal, C., Smith, R. P., & Jarvis, W. R. (1994) · Infection Control and Hospital Epidemiology · doi:10.1086/646867 · Cited by 86
Clostridium Difficile-Associated Diarrhea: Epidemiology, Risk Factors, and Infection Control
Lai, K. K., Melvin, Z. S., Menard, M. J., Kotilainen, H. R., & Baker, S. P. (1997) · Infection Control and Hospital Epidemiology · doi:10.2307/30141489 · Cited by 85
Donskey, C. J., Hanrahan, J., Hutton, R. A., & Rice, L. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315428 · Cited by 76
Paterson, D. L. (2002) · Clinical Infectious Diseases · doi:10.1086/340532 · Cited by 65
Self-citationClostridium difficile -Associated Diarrhea: Epidemiology, Risk Factors, and Infection Control
Lai, K. K., Melvin, Z. S., Menard, M. J., Kotilainen, H. R., & Baker, S. P. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/647687 · Cited by 51
Nelson, D. E., Auerbach, S. B., Baltch, A. L., Desjardin, E. K., Beck‐Sagué, C. M., Rheal, C., Smith, R. P., & Jarvis, W. R. (1994) · Infection Control and Hospital Epidemiology · doi:10.2307/30145537 · Cited by 47
Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance
Harris, A. D. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-11-200006060-00024 · Cited by 44
Ciprofloxacin and Clostridium difficile-associated diarrhoea
Golledge, C. L., Carson, C. F., O'Neill, G. L., Bowman, R. A., & Riley, T. V. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.2.141 · Cited by 44
Cited by
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Self-citationGupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
The Quinolones: Past, Present, and Future
Andriole, V. T. (2005) · Clinical Infectious Diseases · doi:10.1086/428051 · Cited by 428
Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
Iredell, J., Brown, J., & Tagg, K. (2016) · BMJ · doi:10.1136/bmj.h6420 · Cited by 392
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Evans, S. R., Rubin, D., Follmann, D., Pennello, G., Huskins, W. C., Powers, J. H., Schoenfeld, D., Chuang-Stein, C., Cosgrove, S. E., Fowler, V. G., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ495 · Cited by 361
Metadata
- Authors
- Paterson, D. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-15
- Volume
- 38
- Issue
- Supplement_4
- Pages
- S341-S345
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144261829
- Cited by
- 466
- References
- 44
- FWCI
- 19.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.